Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03106896
Other study ID # 2016-069
Secondary ID
Status Not yet recruiting
Phase N/A
First received March 26, 2017
Last updated April 4, 2017
Start date April 2017
Est. completion date June 2020

Study information

Verified date December 2016
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Postherpetic neuralgia(PHN) is a chronic neuropathic pain syndrome which persists more than 3 months after the resolution of the acute shingles episode. PHN is a complicated neuropathic pain that results from the sustained peripheral injury by herpes zoster and its pathological mechanism in skin and spine has been reported. But the cerebral mechanism is still unclear. Based on the previous study that has proved the reorganization of cerebral functional connectivity in pain chronicity, the investigators hypothesize that the process from acute herpetic pain (AHP) to PHN is also accompanied with the reorganization of functional connectivity.In the study, the investigators intend to use 7 Tesla functional magnetic resonance imaging(fMRI) to observe the difference of brain activity and functional connectivity between acute herpetic pain and PHN. Meanwhile, the investigators examine the evolution of functional connectivity longitudinally in patients who is suffering from acute pain, so as to explore the central mechanism of transition to PHN.


Description:

Postherpetic neuralgia(PHN) is a chronic neuropathic pain syndrome which persists more than 3 months after the resolution of the acute shingles episode. PHN is the most common complication of herpes zoster in the pain clinic and it was reported that 2%-35% patients who suffer from herpes zoster may continue to suffer from PHN. Along with the coming of aging population, advanced age is one of the risk factors and about 20.6% patients aged 50 years and over may translate into PHN from acute herpes zoster . Besides, the proportion may increase with age which not only seriously impacts the quality of patients' life but also causes huge personal and social healthcare burden.

PHN is a complicated neuropathic pain that results from the sustained peripheral injury by herpes zoster and its pathological mechanism in skin and spine has been reported. But the cerebral mechanism is still unclear. In the recent several years, fMRI is widely used in the cerebral mechanism in several diseases due to its no trauma and accurate positioning about brain regions. The existing fMRI research about PHN discovered that the alteration of brain activity and reorganization of cerebral functional connectivity in PHN compared with healthy subjects. Liu,et al. investigated the effects of PHN on resting-state brain activity utilizing arterial spin labeling (ASL) techniques and found that regional cerebral blood flow in left caudate, left insula, left S1, and right thalamus was highly correlated with the pain intensity, and meanwhile, the four brain regions exist functional connectivity with other regions in different degrees. Liang,et al. explored the difference of cerebral activity between acute herpes zoster and PHN and found PHN showed higher regional homogeneity in bilateral thalamus, right cerebellum, right hippocampus, right fusiform gyrus, right insula. They speculated tha the thalamus, cerebellum, insula may be associated with hyperalgesia and hippocampus may be associated with pain memory in PHN patients.

In conclusion, fMRI showed that insula, thalamus, hippocampus, striatum and so on are connected with PHN. And then the investigators are curious about the cerebral alteration before the patient is definitely diagnosed as PHN. Meanwhile it's commonly presented in clinic that why some patients who suffer from herpes zoster can heal without PHN while someone are suffering from PHN in a long time. The investigators assume that cerebral alteration and its functional connectivity are associated with the transition to PHN. That is to say, it's a study of mechanism about the transition from acute herpes zoster pain to PHN. Some studies have shown that the reorganization of neural network, especially the function connectivity between cortex and limbic system, is involved in the transition to chronic back pain and affects the sense, emotion, cognition, movement of pain. Apkarian ,et al. used fMRI to identify intrinsic and extrinsic hippocampal functional connectivity, comparing subacute back pain (SBP, back pain 1-4 mo) and chronic back pain (CBP, back pain﹥1 yr) patients to control subjects. Both groups showed more extensive hippocampal connectivity than CON subjects. They then examined the evolution of hippocampal connectivity longitudinally in SBP patients who recovered (SBPr, back pain decreased﹥20% in 1 yr) and those with persistent pain (SBPp) and found that SBPp and SBPr subjects have distinct changes in hippocampal-cortical connectivity over 1 yr. Specifically, SBPp subjects showed large decreases in hippocampal connectivity with medial prefrontal cortex. These results demonstrated that the reorganization of hippocampal functional connectivity is associated with the transition to chronic back pain. They also found that nucleus accumbens(NAc)-medial prefrontal cortex(mPFC) functional connectivity is also involved in the transition to chronic back pain.

So the investigators hypothesize that the process from acute herpetic pain (AHP) to PHN is also accompanied with the reorganization of functional connectivity.

With the development of technology, 7 Tesla fMRI is coming into our sight. Andreas, et al. showed that 7 Tesla-fMRI with the increased field strength offers marked improvement for the localization of activation foci with high spatial specificity when comparing neural response to painful electrical stimulation with 3 Tesla. In our study, the investigators intend to use 7 Tesla fMRI to observe the difference of brain activity and functional connectivity between acute herpetic pain and PHN. Meanwhile, the investigators examine the evolution of functional connectivity longitudinally in patients who is suffering from acute pain, so as to explore the central mechanism of transition to PHN.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 75
Est. completion date June 2020
Est. primary completion date June 2020
Accepts healthy volunteers
Gender All
Age group 50 Years to 80 Years
Eligibility Inclusion Criteria:

- All participants are more than 50 years old, right-handed. Patients are definitely diagnosed by a clinician for postherpetic neuralgia (PHN), persisting pain more than 3 months after the resolution of the acute shingles episode and have pain intensity greater than 4 on the visual analog scale (VAS 0, no pain; 10, "worst pain imaginable"). Patients who are diagnosed as acute herpes zoster at the initial interview have pain (VAS?4 ) duration of within 7 days after zoster onset. Data are available for healthy control subjects with age and sex matched.

Exclusion Criteria:

- Subjects are excluded if they are suffering from eyes, ears, viscera, meninx herpes zoster and asymptomatic special herpes zoster. Those who report any other acute and chronic painful conditions, systemic disease, history of head injury, psychiatric diseases, or more than mild depression [(score > 19, according to Beck's Depression Inventory (BDI)] are also excluded. Subjects are excluded if they were found abnormal signal when scanning by fMRI and exist MRI contraindication, such as existence of magnetic metal in body, claustrophobia and so on. Patients who don't withdraw the analgesic medication (oxycodone, NSAIDS, gabapentin, etc.) the day before and on the day of examination are also excluded.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Second Affiliated Hospital, School of Medicine, Zhejiang University

Outcome

Type Measure Description Time frame Safety issue
Primary functional connectivity between several brain regions The functional connectivity between several brain regions in AHP group and PHN group is different. Besides, the reorganization of cerebral functional connectivity in the process of transition to postherpetic neuralgia is relevant with the chronicity of symptom. AHPand CON subjects are scanned at four visits over the course of six months to observe the variation trend of connectivity from the AHP to PHN. PHN group need only one scanning.
See also
  Status Clinical Trial Phase
Completed NCT04546334 - Erector Spinae Plane Block in Post-herpetic Neuralgia N/A
Terminated NCT01744522 - Leech Therapy for Postherpetic Neuralgia N/A
Completed NCT01688947 - Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN) Phase 2
Completed NCT00478179 - Study of a Bupivacaine Patch (Eladur™) to Treat Post- Herpetic Neuralgia Phase 2
Completed NCT00566904 - New Topical Treatment for Continued Pain After Shingles Phase 1
Completed NCT04099706 - Treatment of Chronic Postherpetic Pain With Autologous Fat Grafting - A RCT N/A
Terminated NCT01603394 - Pilot Study Of Pregabalin And Prediction Of Treatment Response In Patients With Postherpetic Neuralgia Phase 4
Completed NCT01228838 - Study of NGX-1998 for the Treatment of Postherpetic Neuralgia Phase 2
Completed NCT01251211 - Botulinum Toxin in Peripheral Neuropathic Pain Phase 4
Completed NCT00612105 - Safety/Efficacy Study of Retigabine vs. Placebo in Post-Herpetic Neuralgia (PHN) Phase 2
Recruiting NCT04560361 - The Analgesic Effect of Electroacupuncture on Postherpetic Neuralgia N/A
Recruiting NCT05568186 - Correlation Between Thermal Patterns of Infrared Thermal Imaging and Clinical Phenotype in Patients With Postherpetic Neuralgia
Recruiting NCT04664530 - The Study on the Esketamine in the Treatment of Postherpetic Neuralgia Phase 4
Active, not recruiting NCT01508676 - Effects of Pennsaid on Clinical Neuropathic Pain N/A
Completed NCT00885586 - Acupuncture in Herpes Zoster Neuralgia (ACUZoster) Phase 4
Completed NCT00981227 - Efficacy and Safety of Eslicarbazepine Acetate as Therapy for Patients With Post-Herpetic Neuralgia Phase 2
Completed NCT00576108 - A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN) Phase 2
Completed NCT00238511 - An Open-Label Follow-on Trial to Assess the Long-Term Safety and Efficacy of Oral SPM 927 in Subjects With Postherpetic Neuralgia (PHN) Phase 2
Completed NCT00007501 - Shingles Prevention Study Phase 3
Completed NCT04594226 - Electroacupuncture Therapy for Treating Postherpetic Neuralgia N/A